Introduction 34
The twin-arginine protein transport (Tat) pathway operates in parallel with the general 35 secretory (Sec) pathway to export proteins across the cytoplasmic membrane of bacteria and 36 the thylakoid membrane of plant chloroplasts. Substrates are targeted to the Tat pathway by 37 N-terminal signal peptides containing a conserved twin-arginine motif and are transported 38 across the membrane in a folded state driven by the protonmotive force (Berks, 2015 ; Cline, 39 2015; Palmer and Berks, 2012) . 40
The Tat machinery comprises membrane proteins from the TatA and TatC families. TatA The twin arginine motif of the signal peptide is recognised by the cytoplasmic surface of TatC 57 (Gerard and Cline, 2007; Rollauer et al., 2012) . The signal peptide can also bind more deeply 58 within the receptor complex, contacting residues in the transmembrane helix (TM) of TatB and 59
TatA occupying a second binding site primarily located at TatC TM6. We go on to show that 87 in the presence of over-expressed Tat substrate TatA and TatB move positions to occupy 88 each other's binding sites. We propose that signal peptide-triggered position switching of TatA  89 and TatB is a critical step in driving the assembly of an active Tat translocase. 90 91 92
Results

93
The TatB TM is positioned close to TM5 of TatC at the polar cluster site under resting 94
conditions. 95
Prior studies analyzing disulfide crosslinking between E. coli TatB and TatC have used 96 isolated membrane fractions harboring elevated copies of Tat components produced from 97 multicopy plasmids. Under these conditions an initial contact site between TatB L9C and 98
TatC M205C was identified (Kneuper et al., 2012) , which was subsequently extended to reveal 99 further contacts between Cys residues introduced into the TM of TatB and into TM5 of TatC 100 (Rollauer et al., 2012) . To explore whether the same contact sites were detectable in vivo, we 101 developed a protocol for disulfide crosslinking in intact cells using the TatB L9C -TatC M205C 102 crosslink. In these experiments, the Cys-substituted variants of TatB and TatC were produced 103 from the low copy number plasmid p101C*BC, which expresses tatBC at approximately 104 chromosomal level (Alcock et al., 2013), in a strain lacking chromosomal tatBC. An initial 105 titration with the oxidant copper phenanthroline (CuP) revealed that a TatBC crosslink was 106 detectable when CuP was used at 1.2 and 1.8mM ( Fig 1A) . We also noted that TatB and TatC 107 homodimers were formed through the introduced Cys residues after incubation with CuP, as 108 reported previously (Kneuper et at all time points, including the earliest time point tested, however, incubation times with CuP 112 in excess of one minute saw a significant reduction in the recovery of cells (Fig 1C) . We 113 therefore chose to use a 1 min incubation with 1.8mM CuP for all subsequent crosslinking 114
analysis. 115
Next we introduced Cys residues into a scanning region of TatC from residue 205 in TM5, 116 through the periplasmic P3 loop as far as residue 216 in TM6 (Fig 2A) . Fig S1A shows that  117 when each of these TatC Cys substitutions was co-produced with TatB L9C , cells were able to 118 grow in the presence of 2% SDS. This indicates successful export of Tat substrates AmiA and 119
AmiC (Ize et al., 2003) and therefore that the Cys substitutions did not abolish Tat transport 120 activity. Following incubation of cells producing each of these variants with CuP, a TatBC 121 heterodimer was primarily detected between TatB L9C and TatC M205C (Fig 2B,C) . A faint TatBC 122 heterodimer band was also seen between TatB L9C and TatC L206C , and a fainter one between 123 TatB L9C and TatC F213C that was only detected with the anti-TatB antibody (indicated with 124 asterisks on Fig 2B) . It should be noted that the TatB antiserum used in this scanning 125 experiment is a polyclonal anti-peptide antibody that primarily recognizes the C-terminal 15 126 amino acids of TatB and detects the TatB homodimer as a doublet band (Fig S2) hydrogen bond with both of T208 and Q215 when bound at this site. We were unable to 131 explore this directly by disulfide crosslinking since a Cys substitution at TatB E8 abolished Tat 132 activity when expressed from plasmid p101C*BC (Fig S1A) . This is consistent with the loss of 133 activity noted for a TatB E8A substitution, which resulted in destabilization of the TatB-TatC 134 interaction (Alcock et al., 2016). However, molecular modelling indicates that when TatB 135 interacts with TatC via the polar cluster, L9 of TatB is positioned within 6.6Å of TatC M205 136 (backbone distances; Fig 2D) . We therefore conclude that the disulfide crosslink formed 137 between TatB L9C and TatC M205C arises from interaction of TatB at the TatC polar cluster site. 138
To confirm this we undertook disulfide crosslinking between TatB G16C and TatC V198C (Fig 2D)  139 which are one of the most highly co-varying pair of residues at the polar cluster site (Alcock et 140 al., 2016). Fig 2E shows that, as expected, a crosslink is formed between these two cysteine 141 residues when cells were oxidized. These results give full support to the binding mode of TatB 142 described previously (Alcock et al., 2016) . 143
Experiments using a variant of TatC that is unable to bind signal peptides (TatC F94A,E103A ) led 144 to the conclusion that the interaction of TatB at the TatC polar cluster site occurred when the 145
Tat system was at rest (Alcock et al., 2016 In the resting Tat system TatA interacts at a distinct site on TatC close to TM6. 150
Next we used a similar approach to determine whether we could detect in vivo interactions 151 between TatA and TatC. Initially, Cys-substituted variants of TatA and TatC were produced 152 alongside TatB under control of the lac promoter from plasmid pQE60 and expressed in strain 153 DADE-P (Lee et al., 2006 ) that lacks chromosomally encoded tatABC/tatE and which harbors 154 the pcnB1 allele to limit plasmid copy number to 1-2 per cell (Lopilato et al., 1986) . Cys 155 substitutions were introduced at L9, L10 and I11 of TatA and these were tested with the same 156
Cys-scanning region from residues 205 -216 of TatC. 157
First we confirmed that Tat activity was not abolished following introduction of any of these 158 substitutions by showing that each pair of Cys-substituted proteins was able to support growth 159 of DADE-P in the presence of 2% SDS (Fig S1B,C) . Subsequently we undertook crosslinking 160 analysis in vivo using the same protocol as that used for TatB-TatC crosslinking. Under the 161 conditions tested, no crosslinks were detected between TatA and the TatC polar-cluster 162 residue M205C (Fig 3A, Fig S3) , indicating that TatA is not present at this site. Instead, a band 163 of the expected size for a TatA-TatC heterodimer was detected under oxidizing conditions in 164 cells co-producing TatA L9C and TatC F213C . This was confirmed as a crosslink between TatC 165 and TatA since it was also cross-reactive with an anti-TatA antibody (Fig 3B) . A similar band 166 was also detectable under oxidizing conditions when TatA L9C and TatC F213C were produced 167 alongside wild type TatB at much lower levels from plasmid pTAT101 (Fig 3C) . Scanning 168 analysis using TatA L10C revealed a faint crosslink with TatC V212C following oxidation (Fig S3A) , 169
and TatAI11C gave detectable crosslinks with TatC V212C and TatC F213C (Fig S3B) . 170
Taken together, the absence of a TatA crosslink at the the TatA/TatC crosslinks identified above we were able to dock TatA into a binding site that 176 lies adjacent to the polar cluster site (Fig 3D; Fig 4) . Atomistic molecular dynamic simulations 177 suggested that TatA was stable in this site (Fig S4A) and together with the modelling predicted 178 further contacts between TatA and TatC including S5-F213, I6-V212 and A13-I220. To confirm 179 this we constructed cysteine substitutions at each of these predicted pairs, and were able to 180 detect oxidant-induced TatA-TatC heterodimers at each of these positions (Fig 3E-G TatA is bound at the TatA constitutive site. Molecular modelling indicates that both of these 194 sites can be simultaneously occupied on a single TatC (Fig 4A) . Atomistic molecular dynamics 195 suggest that this ternary complex is stable as a TatA 1 B 1 C 1 heterotrimer (Fig S4A) , with stability 196 further increased for an TatA 3 B 3 C 3 oligomer (Fig S4B) , and structural stability plots indicate 197 that the secondary structure in the starting models was preserved (Fig S6A,C) bind at the TatA constitutive site and that it can stably occupy that site when TatA is bound at 248 the polar cluster site (Fig S5, S6B) . A model for the substrate-activated state of the TatABC 249 complex is shown in Fig 4B . where suppressors of inactive twin arginine signal peptides or a defective signal peptide 295 binding site were identified that located to the TM of TatB. Crosslinking analysis indicated that 296 at least some of these TatB variants caused rearrangement at the polar cluster site, probably 297 by decreasing TatB binding affinity at this site and/or increasing binding affinity for the 298 constitutive site (Huang et al., 2017) . 299
In addition to changes in TatA and TatB crosslinking patterns, we note that signal peptide 300 binding also resulted in the formation of TatB homodimers through L9C, and TatC homodimers 301 All plasmids used in this study are listed in Table S1 . Plasmid pUNITATCC4 encodes TatA, 334
TatB and cysteine-less TatC in plasmid pQE60. Production of the encoded proteins is driven 335 by the phage T5 promoter which is constitutively active in strains deleted for lacI, such as 336 TatB-F and SpHI-TatC-R (Table S2) , introducing a SphI site at the 3'-end of tatC. The PCR 347 product was digested with BamHI/SphI and cloned into similarly-digested p101C*BC. All point 348 mutations in plasmids were introduced by Quickchange site-directed mutagenesis 349 (Stratagene) using the primers listed in Table S2 . Plasmid pQE80-CueO expresses E. coli 350
CueO with a C-terminal his6 tag and has been described previously (Leake et al., 2008) . 351
Phenotypic growth in the presence of 2% SDS was assessed by culturing strains of interest 352 in LB medium containing appropriate antibiotics until an OD 600 of 1 was reached, after which 353 5µL aliquots of culture were spotted onto agar plates containing LB or LB supplemented with 354 2% SDS and appropriate antibiotics. Plates were incubated at 37 o C for 16 hours after which 355 they were photographed. Antibiotics were used at the following concentrations: 356 chloramphenicol (25 µg.ml -1 ), kanamycin (50 µg.ml -1 ) and ampicillin (125 µg.ml -1 ). 357
358
In vivo disulfide cross-linking experiments. 359
For Tat proteins produced at close to native level (from pTAT101 and p101C*BC), the 360 appropriate E. coli strain/plasmid combination was cultured overnight in LB medium containing 361 appropriate antibiotics. Cells were diluted 1:100 into fresh LB medium supplemented with 362 appropriate antibiotics and cultured aerobically until an OD 600 of 0.3 was reached. For the CuP 363 titration experiment, six 25 mL aliquots were withdrawn and each supplemented with fresh LB 364 medium to a final OD 600 of 0.15. The first aliquot was left untreated (control), the second one 365 was supplemented with 10 mM DTT (reducing) and the remainder were incubated with 0.3, 366 0.6, 1.2 or 1.8 mM CuP (oxidising). Cells were incubated for 15 min at 37 o C with agitation, 367 then harvested, resuspended in 1 mL 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 12 mM EDTA, For Tat proteins produced at higher copy from plasmid pUNITATCC4, overnight cultures of 388 DADE-P harbouring pUNITATCC4 were subcultured at 1:100 to inoculate fresh LB containing 389 appropriate antibiotics. When cells reached OD 600 of 0.3, three 2.5 mL aliquots were withdrawn 390 and made up to 5 mL with fresh LB to a final OD 600 of 0.15. These aliquots were treated and 391 quenched as described above after which the cells were harvested at 16000 x g for 1 min and 392 resuspended in 40 μL of 1 x Laemmli buffer lacking -mercaptoethanol (BioRad). 393
For analysis, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 394 performed using Tris-glycine gels (Laemmli, 1970) . 20 l of sample was analyzed in each 395 case. Following electrophoresis, proteins were transferred to nitrocellulose membrane (I-blot® 396 system, Life Technologies). TatA, and TatC were identified using the polyclonal antibodies 397 were generated using Pymol (The PyMol Molecular Graphics System, Version 1.8, 411
Schrödinger, LLC). Multimers were built using TatA-TatC/TatB-TatC disulfide crosslinks as 412 unambiguous constraints for docking using Haddock (Dominguez et al., 2003) . 413
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